title: Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation.
abstract: Eicosanoid metabolism and its relationship with platelet-activating factor and oxygen free radical production in rat pancreas transplantation has been studied herein. Male Sprague-Dawley rats were classified in 4 experimental groups (n = 8 each) as follows: group 1, control; group 2, pancreas transplantation, after 12 hr of organ preservation in University of Wisconsin solution; group 3, same as group 2 with desferrioxamine administration before revascularization of the organ in the recipient rat; and group 4, same as group 3 with administration of a platelet-activating factor antagonist (BN-52021). The results show post-transplantation increases in eicosanoid production in pancreatic tissue. The fact that desferrioxamine and BN-52021 administration could reverse increases in thromboxane B2, leukotriene B4, and 12-hydroxyeicosatetraenoic acid but only BN-52021 affected 6-keto-PGF1 alpha levels suggests the existence of a close relationship between platelet-activating factor and oxygen free radical in eicosanoid production in pancreas transplantation and it points to a differential role of metabolites produced by circulatory cells and endothelial cells.
authors.affiliation: Department of Neurochemistry, CID-CSIC, Barcelona, Spain.
authors.forename: F
authors.initials: F
authors.lastname: Pi
authors.forename: G
authors.initials: G
authors.lastname: Hotter
authors.forename: D
authors.initials: D
authors.lastname: Closa
authors.forename: J
authors.initials: J
authors.lastname: Roselló-Catafau
authors.forename: O
authors.initials: O
authors.lastname: Bulbena
authors.forename: F
authors.initials: F
authors.lastname: Badosa
authors.forename: M
authors.initials: M
authors.lastname: Morris
authors.forename: L
authors.initials: L
authors.lastname: Fernández-Cruz
authors.forename: E
authors.initials: E
authors.lastname: Gelpi
mesh_terms: D000818:Animals; D003676:Deferoxamine / Q000627:therapeutic use*; D004224:Diterpenes; D015777:Eicosanoids / Q000096:biosynthesis*; D046934:Ginkgolides; D007783:Lactones / Q000494:pharmacology*; D008297:Male; D016035:Pancreas Transplantation; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000378:metabolism
chemical_list: D004224:Diterpenes; D015777:Eicosanoids; D046934:Ginkgolides; D007783:Lactones; D010972:Platelet Activating Factor; C045856:ginkgolide B; D003676:Deferoxamine